Acquisition activity Recent asset sale and IP portfolio transfer to SciSparc Ltd. suggests a strategic pivot or refocusing of product lines. This creates an opportunity to discuss potential licensing, partnership, or procurement of existing IP assets for clients seeking proven gastroenterology or GERD-related solutions.

Healthcare leverage Historically serving major health care organizations and government agencies, Xylo’s footprint in regulated sectors indicates readiness to engage in enterprise IT modernization, compliance-driven projects, and secure cloud deployments for large healthcare networks.

Scale and scope With a lean team of 11-50 employees and revenue in the lower mid-market range, there is potential to position Xylo for managed services, staff augmentation, or co-delivery partnerships to scale on larger client engagements without significantly increasing overhead.

Technology foundation Current tech stack featuring PHP, Apache, Microsoft 365, and standard web security practices points to opportunities in modernization programs, migration to cloud-native architectures, and security hardening for mid-market clients seeking cost-effective IT solutions.

Growth signals National client base and recognized customer satisfaction imply a strong referenceability. Proposals could emphasize case-study driven strategies, long-term support contracts, and knowledge transfer models to win new logo opportunities in similar sectors.